Prostatis Group’s Honeywell HON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,053
Closed -$231K 169
2025
Q2
$231K Sell
1,053
-323
-23% -$65.4K 0.07% 146
2025
Q1
$275K Sell
1,376
-428
-24% -$86.6K 0.09% 128
2024
Q4
$384K Buy
1,804
+105
+6% +$21.9K 0.11% 116
2024
Q3
$331K Buy
1,699
+85
+5% +$16.5K 0.11% 108
2024
Q2
$325K Sell
1,614
-2,616
-62% -$498K 0.11% 115
2024
Q1
$818K Buy
4,230
+867
+26% +$163K 0.31% 71
2023
Q4
$665K Buy
3,363
+35
+1% +$6.31K 0.28% 74
2023
Q3
$570K Sell
3,328
-118
-3% -$21.6K 0.28% 63
2023
Q2
$674K Sell
3,446
-162
-4% -$30.1K 0.31% 66
2023
Q1
$651K Buy
3,608
+26
+0.7% +$4.89K 0.34% 60
2022
Q4
$723K Buy
+3,582
New +$684K 0.44% 53

Other funds holding HON

Prostatis Group's HON Position: Q3 2025 in Review

Prostatis Group sold out of Honeywell (HON) in Q3 2025, closing a stake of 1,053 shares — an estimated $231K sold.

Prostatis Group first reported a position in HON in Q4 2022 and held it in 11 quarters. The position peaked at $818K in Q1 2024. 2,650 funds tracked by Wall St. Rank hold HON as of Q3 2025.

  • Prostatis Group reported no remaining Honeywell position as of Q3 2025 after selling out during the quarter.
  • Prostatis Group sold 1,053 Honeywell shares in Q3 2025, an estimated $231K.
  • Prostatis Group first reported a position in Honeywell in Q4 2022 and held it in 11 quarters.
  • Prostatis Group's Honeywell position peaked at $818K in Q1 2024.
  • 2,650 funds tracked by Wall St. Rank held Honeywell as of Q3 2025.

Based on Prostatis Group's 13F filing for Q3 2025, filed 4 Nov 2025.